Tc-99m HMPAO WBC imaging to detect carditis and to evaluate the results of high-dose gamma globulin treatment in Kawasaki disease

Clin Nucl Med. 1992 Aug;17(8):623-6. doi: 10.1097/00003072-199208000-00002.

Abstract

Eighteen patients with Kawasaki disease and suspected carditis (11 boys, 7 girls, mean age 18 months) in acute stages underwent Tc-99m HMPAO WBC imaging of the heart. Signs and symptoms subsided after conventional aspirin therapy and the intravenous injection of high-dose (400 mg/kg per day for 5 days) gamma-globulin treatments. Tc-99m HMPAO WBC imaging of the heart was arranged a second time to evaluate the effects of the treatments for carditis. The results showed that a significant difference existed in the severity of carditis before and after the treatments (P less than 0.001, by signed rank test), 39% (7/18) with significant improvement in severity of carditis, 50% (9/18) without definite change. However, 11% (2/18) became more severely ill after the treatments. Tc-99m HMPAO WBC imaging may be useful in detecting carditis in Kawasaki disease and in evaluating the effects of aspirin plus the newly recommended gamma-globulin for the treatment of carditis in Kawasaki disease.

MeSH terms

  • Child, Preschool
  • Female
  • Humans
  • Immunization, Passive*
  • Infant
  • Leukocytes
  • Male
  • Mucocutaneous Lymph Node Syndrome / complications*
  • Myocarditis / diagnostic imaging*
  • Myocarditis / etiology
  • Myocarditis / therapy
  • Organotechnetium Compounds*
  • Oximes*
  • Radionuclide Imaging
  • Technetium Tc 99m Exametazime
  • gamma-Globulins / administration & dosage*

Substances

  • Organotechnetium Compounds
  • Oximes
  • gamma-Globulins
  • Technetium Tc 99m Exametazime